First Page | Document Content | |
---|---|---|
![]() Date: 2004-07-27 11:26:57Cardiac electrophysiology Pharmaceutical industry Medicine Implanted cardiac resynchronization device Clinical endpoint Artificial cardiac pacemaker Adverse event Clinical trial Cardiology Trials Quick Review Clinical research Science Research | Source URL: www.fda.govDownload Document from Source WebsiteFile Size: 287,50 KBShare Document on Facebook |
![]() | Print Form Alabama Board of Medical Examiners P.O. Box 946, Montgomery, ALOffice-Based Surgery Adverse Event Report FormDocID: 1vm7X - View Document |
![]() | Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines forDocID: 1vily - View Document |
![]() | National Action Plan for Adverse Drug Event PreventionDocID: 1v1KN - View Document |
![]() | Microsoft Word - FINAL-Formatted-University Adverse Weather and Emergency Event Policy -effDocID: 1uZd2 - View Document |
![]() | National Action Plan for Adverse Drug Event PreventionDocID: 1uxaR - View Document |